Navigation Links
Transgenomic Licenses IP From IntegraGen to Develop Genetic Test for Autism
Date:2/24/2010

ing statements" of Transgenomic within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements include, but are not limited to, those with respect to management's current views and estimates of future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services markets. The known risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in Transgenomic's filings with the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to in such statements. Accordingly, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press release is as of the date of the release and Transgenomic does not undertake any duty to update this information, including any forward-looking statements, unless required by law.

SOURCE Transgenomic, Inc.

Back to top

RELATED LINKS
http://www.transgenomic.com
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Transgenomic Presents at 12th Annual BIO CEO & Investor Conference
2. Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit
3. Transgenomic, Inc. Reports Third Quarter 2009 Results
4. Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinsons Disease
5. Transgenomic, Inc. Reports Second Quarter 2009 Results
6. Reminder: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast
7. Webcast Alert: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast
8. Transgenomic, Inc. Announces Appointment of New Board Members
9. Transgenomic, Inc. Reports First Quarter 2009 Results
10. Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast
11. Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimers and Parkinsons Diseases at AAN Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Calif. , May 17, 2013  Cellular ... has achieved 50% enrollment of the total projected ... evaluate the safety and preliminary efficacy of the ... therapy for Knee Osteoarthritis (KOA). To date the ... reported. The Phase I open label ...
(Date:5/17/2013)... -- Insero Health, Inc., a company developing natural compounds to ... disorders, is today reporting top-line results from a Phase ... with drug-resistant epilepsy.  The data are being presented at ... by Dr. Steven Schachter , Harvard ... Board.  In this study, INS001 appeared safe and well ...
(Date:5/17/2013)... May 17, 2013 RURO Inc. ... version 4.1, a versatile refinement to the smart ... solution, improves its advanced methodical management for transgenic ... ezColony 4.1. The network-based platform provides user access ... research. While continuing to emphasize streamlined tasks, such ...
(Date:5/17/2013)... Darrington, WA (PRWEB) May 17, 2013 Tooth ... 5th graders showing active signs of the disease. The World ... children and nearly 100% of adults have cavities. What are ... Research is showing a strong connection between the oral ... why is this disease so rampant, yet it is also ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... , , , WHAT: News conference ... for the Warsaw/Kosciusko County community, WHEN: Wednesday, Sept. 23 at ... 200 Seminary Drive Winona Lake, Ind., ... Brad Bishop, Board President, Kosciusko County Community, ...
... SAN FRANCISCO, Sept. 22 A symposium was held last ... Austria entitled "Beta-blockers may now be beneficial in asthma and ... far Inverseon,s asthma program has advanced in the past couple ... and evidence is accumulating that INV102 is showing pre-clinical activity ...
... , DEERFIELD, Ill., Sept. 22 ... annual Astellas Transplant Scholars Awards , $5,000 educational scholarships awarded ... about how transplant affected their education plans, and how they would ... further education and giving back to the transplant community. , ...
Cached Biology Technology:INV102 Asthma Product Discussed at the European Respiratory Society 2Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back 2Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back 3Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back 4
(Date:5/18/2013)... An increasing number of U.S. children are experiencing ... to research presented at Digestive Disease Week (DDW). ... at the Cleveland Clinic Children,s Hospital found that ... breath compared to their lean counterparts. The pattern ... can be correlated to potential complications associated with ...
(Date:5/17/2013)... residents of all ages will celebrate the science ... on our daily lives during the inaugural Atlanta ... and educators from local museums, corporations, K-12 schools ... 40 different events for children and adults at ... http://atlantasciencefestival.org . , The annual Atlanta Science ...
(Date:5/17/2013)... College study finds human-caused climate change may have ... contradicting a host of recent studies that predict ... , The findings, which appear in the journal ... for survival of a creature thought to be ... tropical cold-blooded animals, especially forest lizards, will be ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3First Atlanta Science Festival set for 2014 2Climate change may have little impact on tropical lizards 2
... will take the lead with three other federal ... Initiative (NRI) and released a solicitation for proposals ... Manufacturing Initiative and technology transfer efforts and supports ... United States that work beside, or cooperatively, with ...
... confirms that a variant on the patatin-like phospholipase-3 (PNPLA3) ... patients with chronic hepatitis C virus (HCV). The PNPLA3 ... important genetic predictor and potential therapeutic target in chronic ... July issue of Hepatology , a peer-reviewed journal ...
... Johns Hopkins University graduate students have invented a device to ... blood vessels in patients who need blood-cleansing dialysis because of ... the skin in a patient,s leg, would give a technician ... opened and closed at the beginning and end of a ...
Cached Biology News:NSF leads interagency collaboration to develop advanced robotics 2NSF leads interagency collaboration to develop advanced robotics 3NSF leads interagency collaboration to develop advanced robotics 4Gene variant increases fatty liver risk and fibrosis progression 2Student team invents device to cut dialysis risk 2
Mouse monoclonal [CAT-1] to Chloramphenicol Acetyltransferase ( Abpromise for all tested applications)....
... MaV203 Competent Yeast Cells are designed for ... 1). S. cerevisiae strain MaV203 contains deletions ... for use with GAL4-based two-hybrid systems. The ... for selection of ProQuest bait and prey ...
mCD-1 10 transcription reactions...
Request Info...
Biology Products: